EP0831920A4 - Nouvelle cathepsine et procedes et compositions d'inhibition de cathepsine - Google Patents
Nouvelle cathepsine et procedes et compositions d'inhibition de cathepsineInfo
- Publication number
- EP0831920A4 EP0831920A4 EP96913917A EP96913917A EP0831920A4 EP 0831920 A4 EP0831920 A4 EP 0831920A4 EP 96913917 A EP96913917 A EP 96913917A EP 96913917 A EP96913917 A EP 96913917A EP 0831920 A4 EP0831920 A4 EP 0831920A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- inhibition
- compositions
- methods
- novel cathepsin
- cathepsin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
- C07K5/06095—Arg-amino acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6472—Cysteine endopeptidases (3.4.22)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US469362 | 1995-06-06 | ||
US08/467,607 US5783434A (en) | 1995-06-06 | 1995-06-06 | Cathepsin and methods and compositions for inhibition thereof |
US467607 | 1995-06-06 | ||
US08/469,362 US5849711A (en) | 1995-06-06 | 1995-06-06 | Cathepsin and methods and compositions for inhibition thereof |
PCT/US1996/006211 WO1996039194A1 (fr) | 1995-06-06 | 1996-04-26 | Nouvelle cathepsine et procedes et compositions d'inhibition de cathepsine |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0831920A1 EP0831920A1 (fr) | 1998-04-01 |
EP0831920A4 true EP0831920A4 (fr) | 2003-03-19 |
Family
ID=27042111
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96913917A Withdrawn EP0831920A4 (fr) | 1995-06-06 | 1996-04-26 | Nouvelle cathepsine et procedes et compositions d'inhibition de cathepsine |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0831920A4 (fr) |
JP (1) | JPH11506923A (fr) |
CA (1) | CA2221684A1 (fr) |
WO (1) | WO1996039194A1 (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE377006T1 (de) * | 1995-11-28 | 2007-11-15 | Cephalon Inc | Aus d-aminosäuren abgeleitete cystein- und serinproteasehemmer |
US6191166B1 (en) | 1997-11-21 | 2001-02-20 | Elan Pharmaceuticals, Inc. | Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis |
US5965614A (en) * | 1996-11-22 | 1999-10-12 | Athena Neurosciences, Inc. | N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6207710B1 (en) | 1996-11-22 | 2001-03-27 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting β-amyloid peptide release and/or its synthesis |
US6642261B2 (en) | 1997-11-21 | 2003-11-04 | Athena Neurosciences, Inc. | N-(aryl/heteroarylacety) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
AR016751A1 (es) * | 1996-11-22 | 2001-08-01 | Athena Neurosciences Inc | Metodo para inhibir la liberacion del peptido beta-amiloide en una celula, composicion farmaceutica y compuestos utiles en dicho metodo |
US6117901A (en) * | 1996-11-22 | 2000-09-12 | Athena Neurosciences, Inc. | N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for use |
US6211235B1 (en) | 1996-11-22 | 2001-04-03 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting β-amyloid peptide release and/or its synthesis |
TR199901603T2 (xx) * | 1996-11-22 | 2000-02-21 | Elan Pharmaceuticals, Inc. | N-(aril/heteroaril/alkilasetil) amino asit amidler, bunlar� i�eren farmas�tik bile�imler ve b�yle bile�ikler kullan�larak �-amiloid peptidinin sal�nmas�n� ve/veya sentezini inhibe etmek i�in y�ntemler. |
US6153652A (en) | 1996-11-22 | 2000-11-28 | Elan Pharmaceuticals, Inc. | N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
DE19648793A1 (de) * | 1996-11-26 | 1998-05-28 | Basf Ag | Neue Benzamide und deren Anwendung |
HRP980093A2 (en) * | 1997-02-28 | 1998-12-31 | Lilly Co Eli | Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting "beta"-amyloid peptide release and/or its synthesis by use of such compounds |
AU1926699A (en) * | 1997-12-18 | 1999-07-05 | Immunex Corporation | Cathepsin dc proteins, dna encoding the proteins, and their use in human cancer prognosis |
US6506782B1 (en) | 1998-02-27 | 2003-01-14 | Athena Neurosciences, Inc. | Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
AU3818799A (en) * | 1998-04-20 | 1999-11-08 | Basf Aktiengesellschaft | Novel heterocyclically substituted amides with cysteine protease-inhibiting effect |
DE19818614A1 (de) * | 1998-04-20 | 1999-10-21 | Basf Ag | Neue substituierte Amide, deren Herstellung und Anwendung |
WO2000024392A1 (fr) * | 1998-10-26 | 2000-05-04 | Sumitomo Pharmaceuticals Company, Limited | Inhibiteur de la formation de beta-amyloide |
EP1336847B1 (fr) * | 2002-02-14 | 2007-12-12 | Biofrontera Pharmaceuticals AG | Inhibiteurs de la Cathepsine Y pour le développement de médicaments pour le traitement de la douleur |
US6974672B2 (en) | 2002-03-19 | 2005-12-13 | Amgen Inc. | Gene amplification in cancer |
EP1347059A1 (fr) * | 2002-03-20 | 2003-09-24 | Biofrontera Pharmaceuticals AG | Cathepsin Y, une cible pour le développment de médicaments pour le traitement d'accidents vasculaires cérébraux |
WO2007054776A2 (fr) * | 2005-11-10 | 2007-05-18 | Orchid Research Laboratories Limited | Composes semblables au stilbene comme inhibiteurs hdac atypiques |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995009838A1 (fr) * | 1993-10-01 | 1995-04-13 | Merrell Pharmaceuticals Inc. | INHIBITEURS DE LA PRODUCTION DE PROTEINES DE β-AMYLOIDE |
EP0652009A1 (fr) * | 1993-08-09 | 1995-05-10 | Eli Lilly And Company | L'identification et l'utilisation des inhibiteurs de la protease aspartic |
WO1995013084A1 (fr) * | 1992-05-11 | 1995-05-18 | Miles Inc. | Identification de la cathepsine d comme protease amyloïdogene de la maladie d'alzheimer |
EP0659418A1 (fr) * | 1993-12-21 | 1995-06-28 | Eli Lilly And Company | 2-Phényl-3-azoylbenzothiophènes pour traiter la maladie d'Alzheimer |
EP0670309A1 (fr) * | 1992-11-20 | 1995-09-06 | Japan Tobacco Inc. | Compose inhibant la prolyle endopeptidase et utilisation pharmaceutique de ce dernier |
WO1996020725A2 (fr) * | 1995-01-06 | 1996-07-11 | Sibia Neurosciences, Inc. | Peptide, analogue peptidique et analogue d'acide amine agissant comme inhibiteurs de protease |
WO1996022966A1 (fr) * | 1995-01-23 | 1996-08-01 | Biogen, Inc. | Inhibiteurs de l'adherence cellulaire |
EP0732399A2 (fr) * | 1990-03-05 | 1996-09-18 | Cephalon, Inc. | Protéases analogues à la chymotrypsine et leurs inhibiteurs |
WO1997030072A1 (fr) * | 1996-02-20 | 1997-08-21 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Inhibiteurs peptidomimetiques de la cathepsine d et des plasmepsines i et ii |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5221607A (en) * | 1989-09-18 | 1993-06-22 | Scios Nova Inc. | Assays and reagents for amyloid deposition |
US5242932A (en) * | 1991-12-17 | 1993-09-07 | The Rockefeller University | Treatment of amyloidosis associated with alzheimer disease |
US5164295A (en) * | 1991-03-06 | 1992-11-17 | The Upjohn Company | Method for identifying amyloid protein-extracellular matrix protein affinity altering compounds |
US5538845A (en) * | 1992-02-05 | 1996-07-23 | Athena Neurosciences, Inc. | Beta-amyloid peptide production inhibitors and methods for their identification |
US5441870A (en) * | 1992-04-15 | 1995-08-15 | Athena Neurosciences, Inc. | Methods for monitoring cellular processing of β-amyloid precursor protein |
CZ181493A3 (en) * | 1992-09-10 | 1994-03-16 | Lilly Co Eli | The use of rhodanine derivative for the preparation of a pharmaceutical composition reducing level of sugar in blood and for treating alzheimer's disease |
US5478857A (en) * | 1993-12-23 | 1995-12-26 | Eli Lilly And Company | Use of PLA2 inhibitors as treatment for alzheimer's disease |
WO1995031192A1 (fr) * | 1994-05-16 | 1995-11-23 | Thomas Jefferson University | Methode et utilisation d'agents pour inhiber la polymerisation de proteines et methodes pour identifier ces agents |
CA2152765A1 (fr) * | 1994-06-30 | 1995-12-31 | Jeroen Elisabeth-Joseph Knops | Methodes pour traiter un trouble physiologique associe a un peptide amyloide beta |
US5523295A (en) * | 1994-07-06 | 1996-06-04 | Brandeis University | Method for treating and preventing alzheimer's disease |
-
1996
- 1996-04-26 JP JP9500507A patent/JPH11506923A/ja active Pending
- 1996-04-26 CA CA002221684A patent/CA2221684A1/fr not_active Abandoned
- 1996-04-26 EP EP96913917A patent/EP0831920A4/fr not_active Withdrawn
- 1996-04-26 WO PCT/US1996/006211 patent/WO1996039194A1/fr not_active Application Discontinuation
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0732399A2 (fr) * | 1990-03-05 | 1996-09-18 | Cephalon, Inc. | Protéases analogues à la chymotrypsine et leurs inhibiteurs |
WO1995013084A1 (fr) * | 1992-05-11 | 1995-05-18 | Miles Inc. | Identification de la cathepsine d comme protease amyloïdogene de la maladie d'alzheimer |
EP0670309A1 (fr) * | 1992-11-20 | 1995-09-06 | Japan Tobacco Inc. | Compose inhibant la prolyle endopeptidase et utilisation pharmaceutique de ce dernier |
EP0652009A1 (fr) * | 1993-08-09 | 1995-05-10 | Eli Lilly And Company | L'identification et l'utilisation des inhibiteurs de la protease aspartic |
WO1995009838A1 (fr) * | 1993-10-01 | 1995-04-13 | Merrell Pharmaceuticals Inc. | INHIBITEURS DE LA PRODUCTION DE PROTEINES DE β-AMYLOIDE |
EP0659418A1 (fr) * | 1993-12-21 | 1995-06-28 | Eli Lilly And Company | 2-Phényl-3-azoylbenzothiophènes pour traiter la maladie d'Alzheimer |
WO1996020725A2 (fr) * | 1995-01-06 | 1996-07-11 | Sibia Neurosciences, Inc. | Peptide, analogue peptidique et analogue d'acide amine agissant comme inhibiteurs de protease |
WO1996022966A1 (fr) * | 1995-01-23 | 1996-08-01 | Biogen, Inc. | Inhibiteurs de l'adherence cellulaire |
WO1997030072A1 (fr) * | 1996-02-20 | 1997-08-21 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Inhibiteurs peptidomimetiques de la cathepsine d et des plasmepsines i et ii |
Non-Patent Citations (1)
Title |
---|
See also references of WO9639194A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO1996039194A1 (fr) | 1996-12-12 |
CA2221684A1 (fr) | 1996-12-12 |
EP0831920A1 (fr) | 1998-04-01 |
JPH11506923A (ja) | 1999-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0831920A4 (fr) | Nouvelle cathepsine et procedes et compositions d'inhibition de cathepsine | |
GB9613043D0 (en) | Improved compositions | |
NZ313189A (en) | Sunscreen compositions | |
HUP9900925A3 (en) | Sunscreen compositions | |
PL321759A1 (en) | Novel thrombosin inhibitors | |
GB9614911D0 (en) | Sunscreen compositions | |
PL328877A1 (en) | Method of inhibiting cathepsin k | |
GB9500577D0 (en) | Compositions | |
ZA9510052B (en) | Sunscreen compositions | |
GB9516909D0 (en) | Refrigerant compositions | |
EP0733547A3 (fr) | Compositions pour matériaux d'ablation | |
GB9508791D0 (en) | Compositions of matter | |
GB9504996D0 (en) | Compositions | |
GB9516371D0 (en) | Compositions | |
GB9516920D0 (en) | Refrigerant compositions | |
ZA961514B (en) | Novel compositions | |
GB9516921D0 (en) | Refrigerant compositions | |
GB9510563D0 (en) | Well inhibition | |
GB9508785D0 (en) | Novel compositions | |
GB9604856D0 (en) | Compositions | |
HUP9601550A2 (en) | Particulale compositions | |
GB9510222D0 (en) | Compositions of matter | |
GB9510719D0 (en) | Novel compositions | |
GB9516919D0 (en) | Refrigerant compositions | |
GB9519109D0 (en) | Compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19971204 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 61K 48/00 A, 7C 12Q 1/68 B, 7C 07H 21/02 B, 7C 07H 21/04 B, 7C 07K 5/06 B |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20030131 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20021101 |